Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep and Circadian Regulation in Diabetic Retinopathy
NCT04547439Phase 2Recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Feb 2021
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in diabetic retinopathy (DR), sponsored by University of Illinois Chicago. Started Feb 2021; status: recruiting.
02
Drugs
melatonin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT04547439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04547439.